Skip to content

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

Home
Pharma applications
Non-pharma applications
CD derivatives
Events
E-ducation

Tag: medical sciences

February 27, 2026 Drug delivery / Pharma applications

5th International Conference Integrative Chemistry, Biology & Translational Medicine

The conference will be held on 25-27 June 2026 in Debrecen. The journey of ICBTM began in 2019 with the

Continue reading

Search for:

Recent Posts

16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
Paul Janssen was born 100 years ago
Adsorption of PFAS to Cationic β-Cyclodextrin Polymers
A cyclodextrin polymer that could change the future of batteries
Virus-Mediated Self-Assembly of Functional Cyclodextrins for Antiviral Inhibition

Tags

alpha-CD atherosclerosis Cancer therapy Captisol Cholesterol Clinical trial conference Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems electrospinning FDA Food gamma-CD Gilead HPBCD hydrogel methyl BCD Nanoparticles Niemann Pick Disease RAMEB remdesivir review SBECD Special issue Sugammadex Synthesis

Follow Us

LinkedIn
X
Facebook

Categories

Agriculture (27)
Analysis (74)
CD as API (357)
CD derivatives (434)
Cosmetics and toilettry (54)
Diagnosis (15)
Drug delivery (818)
E-ducation (63)
Environmental (144)
Events (241)
Food (234)
Gene delivery (22)
Household products (6)
In Hungarian (4)
Life sciences (45)
Non-pharma applications (417)
Other industrial use (113)
Pharma applications (1,223)
Supramolecular systems (44)
Uncategorized (168)

Top Posts

Phosphorylated Beta-cyclodextrin as a New Bone-Targeting Drug Delivery System Could Change the Treatment of Osteoporosis and Other Bone Diseases
How air fresheners work?
Cyclodextrins Meet Spicy Food: HOOAGO
16th Central European Symposium on Pharmaceutical Technology (CESPT 2027)
Potential Glioblastoma Therapy with Cationic Cyclodextrin Polymers as Drug Delivery Excipients
Piroxicam/Cyclodextrin: 35 years on the market
22nd International Cyclodextrin Symposium (ICS-22) in India
HPaCD against Alzheimer Disease
Wasabi's bioactive component 6-MSITC formulated with alfa-cyclodextrin improved memory proven in clinical trial.
HPBCD was tested as a possible therapeutic agent in Amyotrophic Lateral Sclerosis (ALS) model

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Email Address

Join 4,458 other subscribers

Loading Comments...

Write a Comment...

Email (Required)

Name (Required)

Website